Form 4: Alkermes Director Christopher I. Wright Reports Share Disposals Following Stock Unit Vesting
SEC Form 4 Filing
Director Christopher I. Wright reported the disposal of Alkermes plc shares following the vesting of restricted stock units on June 29, 2024.
Summary
- On June 29, 2024, Christopher I. Wright, a director of Alkermes plc, reported transactions involving ordinary shares.
- Wright disposed of 6,104 shares to cover the vesting of restricted stock units.
- Additionally, 1,465 shares were disposed of at a price of $24.1.
- Following these transactions, Wright directly owns 14,416 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director, and does not inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the pharmaceutical industry where stock-based compensation is prevalent.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company director.
Key Dates
| Date | Description |
|---|---|
| 06/29/2024 | Date of the reported transactions: vesting of restricted stock units and share disposals. |
| 07/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.